🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesTirzepatide cardiovascular safety — looking for input Page 8

Tirzepatide cardiovascular safety — looking for input

nancy_portland Mon, Jan 20, 2025 at 3:19 PM 36 replies 2,184 viewsPage 8 of 8
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Jan 31, 2025 at 4:14 PM#36
BiostatsBrad said:
Mendelian randomization evidence supporting GLP-1 pathway modulation for cardiovascular risk: genetic variants in the GLP1R gene region associated…

I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

16 months later: down 63 lbs, off metoprolol, A1C from 8.6% to 5.4%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

Last edited: Jan 31, 2025 at 6:14 PM
2 0amy_econ_NJ, bbq_ray_KC
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jan 31, 2025 at 11:20 PM#37
BiostatsBrad said:
Mendelian randomization evidence supporting GLP-1 pathway modulation for cardiovascular risk: genetic variants in the GLP1R gene region associated…

Genuinely useful, thank you. I had the facts and not the framework. Taking it to my next appointment.

Last edited: Feb 1, 2025 at 3:20 AM
3 1dave_SLC, FDA_TrackerJim, ricardo_MIA
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Feb 1, 2025 at 6:26 AM#38

Adding the clinical framing, because it changes how the question reads.

Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 → elevated homocysteine → increased cardiovascular risk marker.

The connection: B12 is a cofactor for homocysteine metabolism. Without adequate B12, homocysteine accumulates. This is ironic — taking a CV-protective medication while developing a CV risk factor from reduced nutrition.

Solution: comprehensive vitamin supplementation and regular lab monitoring. Don't let the medication's benefits be undermined by nutritional deficiencies.

4 2MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Feb 1, 2025 at 1:33 PM#39
GenomicsKate said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

Last edited: Feb 1, 2025 at 4:33 PM
5 3gary_naperville, sean_dublin, hannah_MT and 2 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Feb 1, 2025 at 8:40 PM#40
GenomicsKate said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off amlodipine entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

27 0sarah_nash92, FitDadDave, RunnerRach and 24 others
Reply Quote Save Share Report
1678

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register